Anticonvulsant-induced antinuclear antibodies and lupus-like disease in children.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000974:Antibodies, Antinuclear / Q000032:analysis; D000917:Antibody Formation / Q000187:drug effects; D000927:Anticonvulsants / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005013:Ethosuximide / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects / Q000627:therapeutic use; D007223:Infant; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D008297:Male; D012737:Sex Factors; D014293:Trimethadione / Q000009:adverse effects / Q000627:therapeutic use
D000974:Antibodies, Antinuclear; D000927:Anticonvulsants; D006827:Hydantoins; D005013:Ethosuximide; D014293:Trimethadione